142 related articles for article (PubMed ID: 38029569)
1. Recent developments of P-glycoprotein inhibitors and its structure-activity relationship (SAR) studies.
Zhao X; Di J; Luo D; Vaishnav Y; Kamal ; Nuralieva N; Verma D; Verma P; Verma S
Bioorg Chem; 2024 Feb; 143():106997. PubMed ID: 38029569
[TBL] [Abstract][Full Text] [Related]
2. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
[TBL] [Abstract][Full Text] [Related]
3. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.
Dong J; Qin Z; Zhang WD; Cheng G; Yehuda AG; Ashby CR; Chen ZS; Cheng XD; Qin JJ
Drug Resist Updat; 2020 Mar; 49():100681. PubMed ID: 32014648
[TBL] [Abstract][Full Text] [Related]
4. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review.
Dong J; Yuan L; Hu C; Cheng X; Qin JJ
Pharmacol Ther; 2023 Sep; 249():108488. PubMed ID: 37442207
[TBL] [Abstract][Full Text] [Related]
5. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
[TBL] [Abstract][Full Text] [Related]
6. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods.
Mora Lagares L; Novič M
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499131
[TBL] [Abstract][Full Text] [Related]
8. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z; Lavasanifar A
Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
[TBL] [Abstract][Full Text] [Related]
10. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
12. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer.
Halder J; Pradhan D; Kar B; Ghosh G; Rath G
Nanomedicine; 2022 Feb; 40():102494. PubMed ID: 34775061
[TBL] [Abstract][Full Text] [Related]
13. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
[TBL] [Abstract][Full Text] [Related]
14. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
Bansal T; Jaggi M; Khar RK; Talegaonkar S
J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
[TBL] [Abstract][Full Text] [Related]
15. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
[TBL] [Abstract][Full Text] [Related]
16. Interactions between artemisinin derivatives and P-glycoprotein.
Wang Y; Li Y; Shang D; Efferth T
Phytomedicine; 2019 Jul; 60():152998. PubMed ID: 31301971
[TBL] [Abstract][Full Text] [Related]
17. P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design.
Syed SB; Coumar MS
Curr Top Med Chem; 2016; 16(22):2484-508. PubMed ID: 26873188
[TBL] [Abstract][Full Text] [Related]
18. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
Lin R; Zhang L; Ye B; Wang Y; Li YD; Jason H; Liu W; Hu P; Chen J; Chen ZS; Chen Z
Cancer Lett; 2023 Jun; 563():216181. PubMed ID: 37086953
[TBL] [Abstract][Full Text] [Related]
19. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
[TBL] [Abstract][Full Text] [Related]
20. Zhankuic Acids A, B and C from
Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
